7. Impact of GLP-1 Agonist Weight Loss Drugs on Surgical Wound Complications Following Plastic Surgery Procedures
Saved in:
| Main Authors: | Charles C. Lee, MD, Alice Yau, MD, Rea Chroneos, BS, T. Shane Johnson, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-05-01
|
| Series: | Plastic and Reconstructive Surgery, Global Open |
| Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0001113872.50021.01 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Holding GLP-1 Agonists Prior to Elective Procedures
by: Patient Safety Authority
Published: (2023-12-01) -
Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment
by: Renjiao Liu, et al.
Published: (2025-07-01) -
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
by: Ioannis Ilias, et al.
Published: (2025-01-01) -
Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss
by: Jordan Wean, et al.
Published: (2025-05-01) -
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
by: Ahmad Moolla, et al.
Published: (2025-05-01)